|Titre :||Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: The potential roles for decriminalization and safe supply (2020)|
|Auteurs :||M. BONN ; A. PALAYEW ; S. BARTLETT ; T. D. BROTHERS ; N. TOUESNARD ; M. TYNDALL|
|Type de document :||Article : Périodique|
|Dans :||Journal of Studies on Alcohol and Drugs (Vol.81, n°5, September 2020)|
|Article en page(s) :||556-560|
|Note générale :||
- Use without consequences? Carroll K.M., p. 561.
- Putting the horse before the unicorn: A safe supply strategy should begin with partial agonists. Del Pozo B., Rawson R.A., p. 562-563.
- Unsafe supply: Why making controlled prescription drugs available for unsupervised use will not target the syndemic of HIV, hepatitis C, overdose, and COVID-19. Lembke A., p. 564-565.
|Discipline :||SAN (Santé publique / Public health)|
Thésaurus mots-clésEPIDEMIE ; VIH ; HEPATITE ; USAGER ; PRODUIT ILLICITE ; PRISE EN CHARGE ; DECRIMINALISATION ; DISTRIBUTION CONTROLEE ; SANS ABRI ; OPIOIDES
|Résumé :||People who use drugs (PWUD) face concurrent public health emergencies from overdoses, HIV, hepatitis C, and COVID-19, leading to an unprecedented syndemic. Responses to PWUD that go beyond treatment - such as decriminalization and providing a safe supply of pharmaceutical-grade drugs - could reduce impacts of this syndemic. Solutions already implemented for COVID-19, such as emergency safe-supply prescribing and providing housing to people experiencing homelessness, must be sustained once COVID-19 is contained. This pandemic is not only a public health crisis but also a chance to develop and maintain equitable and sustainable solutions to the harms associated with the criminalization of drug use.|
|Domaine :||Drogues illicites / Illicit drugs|
|Affiliation :||Canadian Association of People Who Use Drugs, Dartmouth, Nova Scotia, Canada|